Implantable Drug Infusion Pumps Market Development Status, Competition Analysis, Type and Application 2027

Implantable Drug Infusion Pumps Market: Drivers and Restraints

Implantable drug infusion pumps market would grow during the forecast years as many multi-national companies are focusing towards new product innovations in implantable drug infusion pumps.

Also, the market for implantable drug infusion pumps would experience a boost owing to growing incidence of pain, cancer and diabetes, rapid increase in geriatric population, technology advancements such as growth in wireless technology and introduction of smart pumps, increase in healthcare expenditure globally and pharmaceutical companies moving there manufacturing bases towards Asia-Pacific region which would reduce the overall cost of the implantable drug infusion pumps.

The market for implantable drug infusion pumps would be affected due to the stringent regulations for new products owing to patient safety risks, high costs, and low reimbursement for implantable drug infusion pumps in the developing countries.

In 2013, U.S. Food and Drug Administration Safety Information and Adverse Event Reporting Program announced regarding various product recalls owing to malfunctioning of implantable drug infusion pumps which delivered drug overdose leading to risks in patient safety, these factors have abstained the patients from the adoption of implantable drug infusion pumps.

Implantable Drug Infusion Pumps Market: Region Wise Outlook

Geographically, the implantable drug infusion pumps market can be segmented into seven regions, North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa.

North America is the most attractive region for the implantable drug infusion pumps market attributing to the robust pharmaceutical industry, a significant number of leading players are located in this region, increasing number of partnerships between technology providers and drug companies.

Followed by which is Europe and Japan as the leading regions in implantable drug infusion pumps market. These markets are also growing significantly due to the focus on the favorable regulatory environment, new product developments for portable and lightweight implantable drug infusion pumps which would ease in the drug delivery method.

Asia Pacific excluding Japan is also expected to show significant growth in implantable drug infusion pumps market due to increase in research and development activities, saturation in the major economies, and development of healthcare infrastructure in this region. Asia-Pacific excluding Japan region has the presence of many small players which are operating at a regional level and contribute to a significant market share of the implantable drug infusion pumps market.